fashion -WSS

fashion

author：entertainment 2025-09-29 01:08:18 - browse：117

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： The Sacklers, horror, and ‘The Fall of the House of Usher’

entertainment

WSS

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Bird flu in dairy cattle: New measures to control spread to humans

The new shift in health care is toward less care

Florida Supreme Court upholds state's abortion ban

Scientific mystery highlights the blind spots in genomics databases

A clever new way to fix Medicaid and graduate medical education

hotspot

fashion

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

10 million people disenrolled from Medicaid over past six months

As demand for Covid shots wanes, Moderna seeks its next success

Excited delirium, Elijah McClain, and emergency physicians

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sanofi CEO defends move to abandon profit guidance, boost research

United colonoscopy coverage change 'may cost lives,' doctors say

Excited delirium, Elijah McClain, and emergency physicians

Tori Bowie and the unacceptable rates of Black maternal death

Medicare Advantage 2025 payments will dip, Biden administration says

focus

Mass General Brigham physicians react to latest merger step

FDA approves Recor Medical high blood pressure device

HPV cancer vaccine study demonstrates efficacy

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Study: New antibiotic targets gonorrhea as well as last existing drug

Harvard scientists, with Google, unveil the most detailed brain map ever

entertainment

leisure time

hotspot

hotspot